Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP907982.RA8s_UdE4sCw-INtVmb8usbZID8w7qFuz9kNFDgBNWZsE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP907982.RA8s_UdE4sCw-INtVmb8usbZID8w7qFuz9kNFDgBNWZsE130_assertion type Assertion NP907982.RA8s_UdE4sCw-INtVmb8usbZID8w7qFuz9kNFDgBNWZsE130_head.
- NP907982.RA8s_UdE4sCw-INtVmb8usbZID8w7qFuz9kNFDgBNWZsE130_assertion description "[Finally, gemcitabine treatment of control animals and p48-Cre/LSL-Kras(G12D) animals with pancreatic cancer caused distinct and up to 60-fold changes in circulating miRs that indicate differential drug effects on normal and cancer tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP907982.RA8s_UdE4sCw-INtVmb8usbZID8w7qFuz9kNFDgBNWZsE130_provenance.
- NP907982.RA8s_UdE4sCw-INtVmb8usbZID8w7qFuz9kNFDgBNWZsE130_assertion evidence source_evidence_literature NP907982.RA8s_UdE4sCw-INtVmb8usbZID8w7qFuz9kNFDgBNWZsE130_provenance.
- NP907982.RA8s_UdE4sCw-INtVmb8usbZID8w7qFuz9kNFDgBNWZsE130_assertion SIO_000772 21738581 NP907982.RA8s_UdE4sCw-INtVmb8usbZID8w7qFuz9kNFDgBNWZsE130_provenance.
- NP907982.RA8s_UdE4sCw-INtVmb8usbZID8w7qFuz9kNFDgBNWZsE130_assertion wasDerivedFrom befree-2016 NP907982.RA8s_UdE4sCw-INtVmb8usbZID8w7qFuz9kNFDgBNWZsE130_provenance.
- NP907982.RA8s_UdE4sCw-INtVmb8usbZID8w7qFuz9kNFDgBNWZsE130_assertion wasGeneratedBy ECO_0000203 NP907982.RA8s_UdE4sCw-INtVmb8usbZID8w7qFuz9kNFDgBNWZsE130_provenance.